[ASAP] Novel SMARCA Degraders for Treating Cancer
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00379 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 30, 2022 Category: Chemistry Authors: Ram W. Sabnis Source Type: research

[ASAP] mRNA Display Reaches for the Clinic with New PCSK9 Inhibitor
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00319 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 26, 2022 Category: Chemistry Authors: Sabrina E. Iskandar and Albert A. Bowers Source Type: research

[ASAP] Resisting Clinical Translation from Bench to Bedside: The China Case of Liver Cancer Therapeutic Revolution
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00359 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 25, 2022 Category: Chemistry Authors: Jianan Huang Source Type: research

[ASAP] LipMetE (Lipophilic Metabolism Efficiency) as a Simple Guide for Half-Life and Dosing Regimen Prediction of Oral Drugs
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00183 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 23, 2022 Category: Chemistry Authors: Giuseppe Cecere, Laura Guasch, Andres M. Olivares-Morales, Kenichi Umehara, and Antonia F. Stepan Source Type: research

[ASAP] Orexin Receptor Agonists as Possible Treatment for Narcolepsy and Idiopathic Hypersomnia
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00358 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 23, 2022 Category: Chemistry Authors: Ahmed F. Abdel-Magid Source Type: research

[ASAP] Inhibitors of Transforming Growth Factor Beta Receptor 1 (TGF βr1) May Enhance the Efficacy of Several Monoclonal Antibodies as Cancer Therapy
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00356 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 23, 2022 Category: Chemistry Authors: Ahmed F. Abdel-Magid Source Type: research

[ASAP] Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of < italic toggle="yes" > N < /italic > ‑Arylated Heliamine Analogues
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00228 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Makito Yamada, Yu Hirose, Bangzhong Lin, Megumi Fumimoto, Kazuto Nunomura, Sirimangkalakitti Natchanun, Naoyuki Takahashi, Yuuta Ohki, Makoto Sako, Kenichi Murai, Kazuo Harada, Masayoshi Arai, Sayo Suzuki, Tomonori Nakamura, Junichi Haruta, and Mitsuhiro Source Type: research

[ASAP] Combination of Cyclin-Dependent Kinase 4 Inhibitors and Androgen Receptor Inhibitors as Cancer Therapy
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00357 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Ahmed F. Abdel-Magid Source Type: research

[ASAP] Biological Effects of Modifications of the Englerin A Glycolate
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00258 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Sarath P. D. Seenadera, Sarah A. Long, Rhone Akee, Gabriela Bermudez, Gregory Parsonage, Jonathan Strope, Cody Peer, W. Douglas Figg, Kathlyn A. Parker, David J. Beech, and John A. Beutler Source Type: research

[ASAP] Application of Deuterated < italic toggle="yes" > N < /italic > , < italic toggle="yes" > N < /italic > ‑Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00354 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Robert B. Kargbo Source Type: research

[ASAP] Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00299 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Ashley M. Lato, Susan J. Burke, Maggie P. Ducote, Brandon J. Kennedy, J. Jason Collier, and Shawn R. Campagna Source Type: research

[ASAP] Application of Compositions Comprising a KRAS G12C Inhibitor and an EGFR Inhibitor for the Potential Treatment of Cancer
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00353 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Robert B. Kargbo Source Type: research

[ASAP] Restoration of Motor Function Post-Neurological Injury Using Serotonergic Agonist
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00352 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 22, 2022 Category: Chemistry Authors: Robert B. Kargbo Source Type: research

[ASAP] Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00349 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 19, 2022 Category: Chemistry Authors: C. S. Brian Chia and Masafumi Inoue Source Type: research

[ASAP] Structure –Activity Relationship and < italic toggle="yes" > In Silico < /italic > Evaluation of < italic toggle="yes" > cis < /italic > - and < italic toggle="yes" > trans < /italic > -PCPA-Derived Inhibitors of LSD1 and LSD2
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00294 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - August 18, 2022 Category: Chemistry Authors: Hideaki Niwa, Chiduru Watanabe, Shin Sato, Toshiyuki Harada, Hisami Watanabe, Ryo Tabusa||, Shunsuke Fukasawa||, Ayane Shiobara||, Tomoko Hashimoto||, Osamu Ohno||, Kana Nakamura, Keiko Tsuganezawa, Akiko Tanaka, Mikako Shirouzu, Teruki Honma, Kenji Matsu Source Type: research